Home | Contact us | Staff | Students | MyExeter (Staff) | exehub (Students) | Site map |

      StudyingResearchBusiness and communityWorking hereAlumni and supportersOur departmentsVisiting usAbout us

      Open Research Exeter (ORE)

      View Item 
      •   ORE Home
      • University of Exeter Medical School
      • Institute of Biomedical & Clinical Science
      • View Item
      •   ORE Home
      • University of Exeter Medical School
      • Institute of Biomedical & Clinical Science
      • View Item
      JavaScript is disabled for your browser. Some features of this site may not work without it.

      Pharmacogenomics in diabetes: outcomes of thiamine therapy in TRMA syndrome

      Thumbnail
      View/Open
      TRMA main text clean corrected_EDF.doc (393Kb)
      Date
      2018-02-15
      Author
      Habeb, AM
      Flanagan, SE
      Zulali, MA
      Abdullah, MA
      Pomahačová, R
      Boyadzhiev, V
      Colindres, LE
      Godoy, GV
      Vasanthi, T
      Al Saif, R
      Setoodeh, A
      Haghighi, A
      Haghighi, A
      Shaalan, Y
      International Neonatal Diabetes Consortium
      Hattersley, AT
      Ellard, S
      De Franco, E
      Date issued
      2018-02-15
      Journal
      Diabetologia
      Type
      Article
      Language
      en
      Publisher
      Springer Verlag
      Links
      https://www.ncbi.nlm.nih.gov/pubmed/29450569
      Rights
      © The Author(s) 2018. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
      Abstract
      AIMS/HYPOTHESIS: Diabetes is one of the cardinal features of thiamine-responsive megaloblastic anaemia (TRMA) syndrome. Current knowledge of this rare monogenic diabetes subtype is limited. We investigated the genotype, phenotype and response to thiamine (vitamin B1) in a cohort of individuals with TRMA-related diabetes. METHODS: We studied 32 individuals with biallelic SLC19A2 mutations identified by Sanger or next generation sequencing. Clinical details were collected through a follow-up questionnaire. RESULTS: We identified 24 different mutations, of which nine are novel. The onset of the first TRMA symptom ranged from birth to 4 years (median 6 months [interquartile range, IQR 3-24]) and median age at diabetes onset was 10 months (IQR 5-27). At presentation, three individuals had isolated diabetes and 12 had asymptomatic hyperglycaemia. Follow-up data was available for 15 individuals treated with thiamine for a median 4.7 years (IQR 3-10). Four patients were able to stop insulin and seven achieved better glycaemic control on lower insulin doses. These 11 patients were significantly younger at diabetes diagnosis (p = 0.042), at genetic testing (p = 0.01) and when starting thiamine (p = 0.007) compared with the rest of the cohort. All patients treated with thiamine became transfusion-independent and adolescents achieved normal puberty. There were no additional benefits of thiamine doses >150 mg/day and no reported side effects up to 300 mg/day. CONCLUSIONS/INTERPRETATION: In TRMA syndrome, diabetes can be asymptomatic and present before the appearance of other features. Prompt recognition is essential as early treatment with thiamine can result in improved glycaemic control, with some individuals becoming insulin-independent. DATA AVAILABILITY: SLC19A2 mutation details have been deposited in the Decipher database ( https://decipher.sanger.ac.uk/ ).
      Description
      This is the author accepted manuscript. The final version is available from Springer Verlag via the DOI in this record
      Citation
      Vol. 61 (5), pp. 1027–1036
      DOI
      https://doi.org/10.1007/s00125-018-4554-x
      URI
      http://hdl.handle.net/10871/32346
      Collections
      • Institute of Biomedical & Clinical Science
      Place of publication
      Germany

      Using our site |  Freedom of Information |  Data Protection |  Copyright & disclaimer |  Privacy & Cookies | 

       

       

      Related Links
      What is ORE Library Site Research Site
      Browse
      All of ORECommunities & CollectionsTitlesAuthorsTypeThis CollectionTitlesAuthorsType
      Statistics
      Most Popular ItemsStatistics by Country

      Using our site |  Freedom of Information |  Data Protection |  Copyright & disclaimer |  Privacy & Cookies |